Health In Tech Inc HIT Q1 2026 Earnings Narrow Loss Beat Expectations Stock Dips 26 on Absent Revenue Details Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline HRTG Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Persist TMO Q1 2026 Earnings EPS Surpasses Estimates by 284 Stock Edges Down WTW Q1 2026 Earnings Adjusted EPS Slightly Beats Estimates Shares Edge Lower GTY Q1 2026 Earnings Strong EPS Beat Drives Modest Share Price Uptick